Emerging PET tracer excels at tau pathology, differentiates dementias
October 29, 2020 -- A new PET radiotracer for tau pathologies is showing promise for helping diagnose and differentiate Alzheimer's disease from a wide range of other dementia disorders. Researchers detailed their early experiences in animal and patient studies in Neuron online October 29. Read More
Use F-18 fluciclovine PET/MRI to stage prostate cancer
October 28, 2020 -- PET/MRI with the F-18 fluciclovine radiotracer shows promise for initial staging of high-risk prostate cancer and for evaluating response to androgen deprivation therapy, according to a pilot study published online October 14 in the American Journal of Roentgenology. Read More
PSMA-PET reveals new salivary glands
October 28, 2020 -- Imaging with the use of prostate-specific membrane antigen (PSMA) has led to the discovery of a pair of salivary glands, found tucked away inside the skull where the nasal cavity and throat meet. The findings were published recently in Radiotherapy & Oncology. Read More
PET with Axumin boosts prostate cancer outcomes
October 27, 2020 -- Patients with recurrent prostate cancer had better outcomes when PET with the Axumin radiopharmaceutical was part of the imaging package guiding their radiation therapy, according to a study presented on October 26 at the American Society for Radiation Oncology annual meeting. Read More
Radiomics can aid management of lung cancer patients
October 26, 2020 -- Researchers from the H. Lee Moffitt Cancer Center and Research Institute in Tampa, FL, have reported that CT radiomics features can help predict tumor behavior in screening-detected lung cancer. They've also found that PET/CT radiomics shows promise for guiding non-small cell lung cancer treatment decisions. Read More
AI aids detection of metastasis on bone scintigraphy
October 13, 2020 -- An artificial intelligence (AI) model was able to help nuclear medicine physicians improve their performance in diagnosing bone metastases on bone scintigraphy exams in patients with breast, lung, prostate, or other cancers, according to research published online October 12 in Scientific Reports. Read More
Impaired blood flow linked to tau buildup in AD patients
October 12, 2020 -- Using MR and PET imaging, researchers from the University of Southern California in Los Angeles have found a connection between impaired blood flow to the brain and tau protein buildup in patients with Alzheimer's disease (AD), according to a study published October 12 in the Journal of Neuroscience. Read More
PET-based optical imaging detects prostate cancer
October 8, 2020 -- A PET-based optical imaging technique called Cerenkov luminescence imaging was successfully used by German researchers to confirm the presence of cancer cells after prostate cancer surgery, according to a study published in the October edition of the Journal of Nuclear Medicine. Read More
FES-PET could predict endometrial cancer outcomes
October 7, 2020 -- PET imaging with the radiotracer F-18 fluoroestradiol (FES) can help determine how well patients will fare after a diagnosis of endometrial cancer, according to a study published October 2 in the Journal of Nuclear Medicine. Read More
Presurgical cardiac stress testing on decline
October 6, 2020 -- Presurgical cardiac stress testing is on the decline, according to a study published September 30 in JAMA Cardiology. The research suggests that efforts from professional organizations to curb unnecessary healthcare interventions through issuing guidelines has been successful. Read More
Special Feature
Ringertz: Nobel prize for PET may lie on the horizon

A Nobel prize for PET imaging could well be on the cards in the years ahead, but identifying the most deserving recipient(s) is no simple task, Prof. Hans Ringertz revealed during ECR 2022. Read more

Conferences
Online Lymphoma Imaging Fellowship
October 10-12
Barcelona, Catalonia Spain
British Nuclear Medicine Society Autumn Meeting 2022
November 11-12
Swansea, West Glamorgan United Kingdom
Radiological Society of North America (RSNA) 2022
November 27 - December 1
Chicago, Illinois United States